Enel Health®Atlas
Sign in
Enel Health®Atlas
Browse libraries

Not medical advice. The Atlas is not a substitute for a clinician who can examine you.

Coloplast Titan / Titan Touch

Coloplast Titan Inflatable Penile Prosthesis (OTR / Touch)

Evidence grade 5 of 5, Settled. Read how the Atlas grades evidence.

The written rationale for this grade is still being prepared.

FDA
FDA Approved (Coloplast Titan series)

Reference only. Not medical advice.

What can go wrong

Same surgical risk profile as any inflatable implant: infection, mechanical failure, erosion, and irreversible loss of native erectile tissue. The hydrophilic coating is designed to absorb an antibiotic solution to reduce bacterial adherence, but it does not eliminate infection risk. Contemporary three-piece IPP series report mechanical survival roughly 81-94% at 5 years, 68-89% at 10 years, and 57-76% at 15 years, spanning both brands.

This is something to take to a clinician. The Atlas can tell you what is known about coloplast titan / titan touch in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.

The Coloplast Titan is the second of the two three-piece inflatable penile prostheses available in the US market and the primary competitor to the Boston Scientific AMS 700. It uses cylinders made of Bioflex, a proprietary polyurethane elastomer, and carries a hydrophilic surface coating that surgeons dip in an antibiotic solution of their choice before implantation. The Titan Touch and one-touch release (OTR) pump were engineered to make deflation easier for patients.

The competing three-piece implant with a hydrophilic coating.

What people take it for

What it is taken for. Approval, where it exists, covers only some of these.

  • Refractory erectile dysfunction
  • Post-prostatectomy ED
  • Severe vasculogenic ED
  • Peyronie's disease with ED

How it works

Mechanically identical in principle to the AMS 700: paired intracorporal cylinders, a scrotal pump, and a fluid reservoir. Pumping inflates the cylinders with saline for an on-demand erection. Coloplast markets the Titan's Bioflex cylinders as offering strong girth expansion and rigidity, and the OTR pump as reducing the learning curve for deflation.

What people get wrong

  • Often saidOne brand is clearly better than the other

    ActuallyHead-to-head evidence shows comparable survival and satisfaction; the practical difference is usually surgeon familiarity and patient anatomy, not a decisive clinical edge.

Who profits, and who pushes back

Nobody is named here yet, because we have not done that work on this entry. Read that as unfinished. Somebody almost certainly sells this, and somebody almost certainly disputes it. Assume both until we have checked.

Set against the alternatives

Systematic review (comparing AMS 700 and Coloplast Titan) found no significant difference in durability, mechanical survival, or satisfaction between the two devices. The Titan is frequently described as producing greater girth rigidity, while the AMS LGX uniquely expands in length. The two dominate the US IPP market between them.

The market for this

What follows describes how this is bought and sold. It is not a buying guide and it is not an endorsement of any seller.

Comparable to the AMS 700; typically insurance-covered when prior therapies have failed. All-inclusive packages are frequently quoted around $10,000-$14,500 where paid out of pocket.

At a glance

Pieces
3 (cylinders, pump, reservoir)
Cylinder material
Bioflex polyurethane
Coating
Hydrophilic (surgeon-loaded antibiotic)
Pump
One-Touch Release (OTR) / Titan Touch
Manufacturer
Coloplast

What this entry does not yet cover

What follows is unfinished work on our side, not a finding about Coloplast Titan / Titan Touch. A short entry is not a safe entry.

  • Timeline. We have not built the dated record of research and regulatory events.
  • Supply chain. We have not mapped where it is made.
  • Who uses it. We have not documented the user groups.
  • What could change. No forward-looking summary yet.
  • Children and teenagers. We have not checked what is known about younger people.
  • Where we land. We have not taken a position on this yet.

Sources

The studies below are named and described, but not linked. You cannot open them from here and check our reading against them, which means this page is our summary of the literature rather than a document you can verify. Weigh it accordingly until the links exist.

The studies that matter

  • Contemporary 3-piece IPP mechanical-survival pooled figuresreported

    ~81-94% (5 yr), ~68-89% (10 yr), ~57-76% (15 yr) mechanical survival

  • Titan patient/partner satisfaction seriesreported

    Patient satisfaction ~85% and partner ~72% in one study; other series report 92-100% patient satisfaction

  • Shaw & Garber, OTR pumpreported

    Statistically fewer training sessions needed to master deflation vs the prior pump